Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2018-11-26
2019-01-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Evaluation of Clinical Equivalence Between iX and PID
NCT03967405
MolecuLightDX Measurement Feature Clinical Validation
NCT06682923
Evaluation of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to Clinical Signs and Symptoms for the Identification of Bacteria-containing Wounds
NCT03540004
Presence of Fluorescence Signature to Predict Graft Failure Using MolecuLight i:X
NCT04185636
Point-spectroscopy Trial
NCT05183698
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fluorescence Imaging Device
Hand-held, real-time fluorescence imaging device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Wound size less than 15 cm in length
* 18 years or older
Exclusion Criteria
* Subjects with recent (\<30 days) biopsy or curettage of target wound
* Subjects with wounds that cannot be completely imaged by study device due to anatomic location
* Unable or unwilling to consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MolecuLight Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ron Linden, MD
Role: PRINCIPAL_INVESTIGATOR
Judy Dan Research and Treatment Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Judy Dan Research and Treatment Centre
North York, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.